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Structure analysis and ensemble refinement of the apo-structure of thymidine
diphosphate (TDP)-rhamnose 30 -O-methyltransferase reveal a gate for substrate entry
and product release. TDP-rhamnose 30 -O-methyltransferase (CalS11) catalyses a 30 O-methylation of TDP-rhamnose, an intermediate in the biosynthesis of enediyne
antitumor antibiotic calicheamicin. CalS11 operates at the sugar nucleotide stage
prior to glycosylation step. Here, we present the crystal structure of the apo form of
CalS11 at 1.89 Å resolution. We propose that the L2 loop functions as a gate facilitating and/or providing specificity for substrate entry or promoting product release.
Ensemble refinement analysis slightly improves the crystallographic refinement statistics and furthermore provides a compelling way to visualize the dynamic model of
C 2016
loop L2, supporting the understanding of its proposed role in catalysis. V
Author(s). All article content, except where otherwise noted, is licensed under a
Creative Commons Attribution (CC BY) license (http://creativecommons.org/
licenses/by/4.0/). [http://dx.doi.org/10.1063/1.4941368]
I. INTRODUCTION

Natural products remain invaluable sources for drug leads and bioactive probes.1,2
Discovering new mechanisms for the biosynthesis of important natural products and exploiting
knowledge of natural product biosynthesis enzymes could help produce new diversified biosynthetic or semisynthetic natural products for various purposes.3–6 As part of the NIH Protein
Structure Initiative, a high-throughput structural genomics approach has been employed to
clone, express, purify, and solve structures of novel enzymes for natural product biosynthesis.7–18 One targeted pathway for this initiative has been that leading to the biosynthesis of calicheamicin (CLM), a 10-membered enediyne antitumor antibiotic produced by Micromonospora
echinospora.19,20 Upon bioreduction, CLM undergoes a Bergman-type cyclization reaction, the
benzene diradical species of which lead to DNA backbone hydrogen abstraction and subsequent
irreparable oxidative DNA strand scission.21,22 CalS11, a protein encoded by the calicheamicin
biosynthetic gene locus,23,24 catalyzes a late-stage glycosyl tailoring event (thymidine diphosphate (TDP)-L-rhamnose 30 -O-methylation) prior to glycosyltransferase (CalG1)-catalyzed
transfer to complete aryltetrasaccharide assembly (Figure 1).10,25 Like all prototypical class I
methyltransferases,26 CalS11 uses S-adenosylmethionine (AdoMet, SAM) as the methyl donor.
However, CalS11 is distinguished from other sugar O-methyltransferases by virtue of its activity at the sugar nucleotide prior to glycosyltransfer.10,27
Structural flexibility and dynamics are generally key for protein function.28 Functionally
important motions not only involve ordered secondary structures but more commonly involve
disordered loop structures. As shown by the study on CalS11 and many other proteins, such as
xylanase protein from Thermobacillus xylanilyticus,29 loop dynamics are important for substrate
a)
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FIG. 1. The biosynthetic pathway of TDP-methoxy-rhamnose in M. echinospora en route to calicheamicin !1I production.

binding and product release. Loop dynamics are also important for allosteric activation of
enzymes, such as kinases and tyrosine phosphatases.30 Loop dynamics are also widely found in
eukaryotic regulatory proteins involved in processes such as signal transduction and transcription, allowing for an induced fit molecular recognition process.
However, prevailing static models are simply an average of an ensemble of states and cannot
adequately describe the dynamics of protein molecules. Ensemble refinements (ERs) have been
developed that use the X-ray diffraction data to generate an ensemble of models to represent a
non-Gaussian distribution of positions and imply the corresponding motions of the protein molecules. This concept was first proposed two decades ago by Brunger and Kuriyan31 and was
extended and tested by several other groups of scientists.32,33 Burnley et al. developed an implementation (phenix.ensemble_refinement) as part of the Phenix software package33 which lowers
the barrier for others to use this approach. Starting from a well-refined single model, local molecular vibrations and rotations are sampled by molecular dynamics (MD) simulation restrained with
terms incorporating the X-ray data, while global disorder is partitioned into an overall translationlibration-screw (TLS) model.33 Large numbers of structures make up the ensemble, typically
thousands, but in the end, a small number of structures that reproduce the best Rfree within some
tolerance, typically 0.1%, are kept as the final representative set of structures defining the ensemble. We have applied ER techniques to model both the structure and dynamics based on X-ray
diffraction data sets for both S-adenosylhomocysteine (SAH) bound and apo-structures. The analysis shows the L2 loop is indeed highly flexible in ways that are consistent with enzymatic turnover, whereas the highly conserved loops L1 and L3 have dramatically more stable structures.
We previously solved and reported two structures of the SAH bound form of CalS11 [Protein
Databank (PDB) entry 3TOS, 4GF5]10 and have now solved the corresponding apo structure of
CalS11 at 1.89 Å resolution (PDB entry 4PWR). Compared to its substrate bound structure,10
where loop L2 is closed over the SAH, the electron density for loop L2 in the apo-form is inadequate for establishing a static model, reflecting the dynamic, or at least disordered nature of substructure L2. The observed structural difference in the states of CalS11 with and without SAH
bound prompted further evaluation of the structural dynamics of CalS11 in its catalytic function.
II. MATERIALS AND METHODS
A. Crystallization and data collection and refinement

Protein cloning, expression, and purification methods were performed as previously
described.10 Apo CalS11 crystals were grown with hanging drop vapor diffusion method by
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mixing 1 ll of protein solution (16 mg/ml CalS11 in 25 mM tris, pH 8.0) and 1 ll reservoir
solution (25% polyethylene glycol 3350, 0.2 M Li2SO4, 0.1 M Bis-Tris pH 6.5). The crystal
was flash frozen in liquid nitrogen for data collection without additional cryoprotectants.
Diffraction data were collected at APS 21-ID-D beamline and were processed with XDS.34
The apo structure was solved by molecular replacement using phaser-MR from Phenix
suite35 with molecule A from CalS11 complex structure (PDB 4GF5) as the search model.
The model was improved by alternating cycles of manual model building using Coot36 and
refinement using Phenix. Visual analysis of the final difference maps and interpretation of
the structure was performed with a collaborative stereoscopic system based on a commodity
3D television.37 The final model was validated using MolProbity38 and deposited in the
Protein Data Bank with accession code 4PWR.

TABLE I. Statistics for data collection and refinement of the crystal structure of CalS11. Values in parenthesis are for the
highest resolution shell.
PDB ID

4PWR

Spacegroup
Wavelength (Å)

C121
0.9787

Unit cell parameters
Estimated standard deviation of cell parameters
Resolution range of data collection (Å)
No. of reflections (measured/unique)
Completeness % (Å)Multiplicity
Mean I/sigma(I)
Wilson B-factor

148.26 125.14 107.15 90.00 125.12 90.00
0.14 0.09 0.07 0.00 0.03 0.00
47.85  1.793 (1.857  1.793)
1 098 192/147 725 (91 275/13 326)
99 (90)7.4 (6.8)
10.25(1.39)
25.40

R-mergea

0.1316 (1.234)

R-measb
CC1/2

0.1415 (1.332)
0.997 (0.611)

CC*

0.999 (0.871)

R-crystc
R-freed

0.146 (0.298)
0.179 (0.317)

Number of non-hydrogen atoms

11 176

Macromolecules
Ligands

9403
25

Protein residues

1162

RMS(bonds)
RMS(angles)

0.01
1.0

Ramachandrane favored (%)

97.0

Ramachandran outliers (%)
Rotamer outliers (%)

0.09
0.69

Clashscore

3.15

Average B-factor
Macromolecules

32.8
30.7

Ligands

64.1

Solvent

43.24

P P
P P
R-merge ¼ hkl jjIhkl,j  hIhklij/ hkl j Ihkl,j, where hIhkli is the average of symmetry related observation of a unique
reflection. P pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
P P
b
R-meas ¼P hkl n=ðn  1Þ jjIP
hkl,j  hIhklij/
hkl
j Ihkl,j, which is redundancy independent version of R-merge.
c
R-cryst ¼ hkl jjFobsj  jFcalcjj/ hkl jFobsj, where Fobs and Fcalc are the observed and calculated structure-factor
amplitudes.
d
R-free was calculated as R-work using randomly selected 5% of the unique reflections that were omitted from the structure
refinement.
e
Ramachandran statistics indicate the percentage of residues in the most favored, additionally allowed, and outlier regions
of the Ramachandran diagram as defined by MOLPROBITY.
a

012004-4

Han et al.

Struct. Dyn. 3, 012004 (2016)

B. Ensemble refinement of CalS11

We performed refinement using the scripts within Phenix.ensemble_refinement for both the
substrate bound (PDB 3TOS, 4GF5)10 and unbound structures of CalS11 (PDB 4PWR). For the
substrate bound structure, the downloaded PDB files were refined using TLS refinement before
being used as input file for ensemble refinement. For the apo CalS11 structure, after regular
phenix.refine step, the missing region of L2 was arbitrarily built in manually with correct
sequence and stereochemistry and was subsequently used as input for the ensemble refinement.
We limited the number of models to be used to prevent over fitting of the data.33 Harmonic
restraints were applied for all amino acids with visible electron density at a level of 1r in the
2mFo-Dfc electron density map using parameters weight ¼ 0.0001 and slack ¼ 1.0, as suggested
in the documentation.
III. RESULTS AND DISCUSSION
A. Overall structure of apo CalS11

The structure of the apo CalS11 crystal was determined at a nominal resolution of 1.89 Å.
This structure belongs to space group C2, different from previously reported space groups of
CalS11, P1. The final structure was refined to Rcryst and Rfree of 13.3% and 16.8% (PDB entry
4PWR) (Table I). Each CalS11 monomer folds in the same way as the substrate bound form
(Figure 2(b)), into a single globular domain comprising a Rossmann fold characteristic of all
SAM-dependent methyltransferases. Apo CalS11 also forms a decamer of five interconnected
dimers. Each asymmetric unit contains half of the functional decamer (Figure 2(a)). In the
search results for similar structures, NovP, the novobiocin L-noivose-40 -O-methyltransferase is
the closest structure available. Different from CalS11’s decameric structure, NovP exists as
dimer in solution. The C-alpha coordinates root-mean-square-deviation (r.m.s.d.) of NovP
aligned with CalS11 is 3.2 Å for the bound structure and 1.9 Å for the apo structure. The

FIG. 2. (a) The apo form of CalS11 forms a decamer in solution. Each asymmetric unit contains half of a decamer (shown
with colors). (b) Apo CalS11 monomer with secondary structural element, L2, labelled. (c) The SAH/glutamate complex
CalS11 monomer structure (PDB 3TOS10). (d) The SAH complex NovP monomer structure (PDB 2WK139). (e)
Superimposition of apo (red) and complexed (blue) CalS11 structures. (f) Superimposition of NovP structure (green) and
CalS11 complexed structure (blue).
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sequence identity of NovP and CalS11 is 20%. The Rossmann fold part of the structures aligns
well, while the L2 regions of these two structures are fairly distinct.
Out of the 257 residues in the apo form of CalS11, 6 N-terminal residues and the residues 111–131
are missing in the electron density. It is unlikely that this stretch of protein chain has been cleaved, since
these residues are visible in the substrate-bound structures. Thus, the most likely possibility is that the
L2 region of CalS11, residues 111–131, undergoes large conformational changes when no substrate is
present. The L2 region is adjacent to the substrate-binding cavity. It is likely that the dynamics of L2
facilitates substrate entry and product release. Large conformational changes of L2 are accommodated
despite the decameric structure of the enzyme as this loop is on the surface of the decamer.
B. Active site of apo CalS11

The CalS11 substrate bound structure shows that the SAM/SAH binding site of CalS11 is located
in the C-terminal end of the cleft formed by the central b strands. Interactions between CalS11 and the
bound SAH as well as the substrate surrogate, glutamate, are mainly provided by residues in three
loops (L1, L2, L3), which are conserved in the methyltransferase family. The conformation of these
residues of L1 (between b1 and a4) and L3 (between b3 and helix a6) in the apo structure is mostly
the same as they are in the complex structure, including the putative CalS11 catalytic base Asp191
(Figure 3). Though many residues of L2 (between b2 and a5) are also conserved, residues 111–128
(or residues 111–132 in some chains) are not visible in the apo structure. In 2 copies out of 5 in asymmetric unit of the apo structure, residues 127–133 of L2 are shifted away from the SAM/SAH site
compared to that in the complex structure (Figure 2(e)). In the other 3 copies in the ASU, only residues
132–133 are visible and they show same conformation as the complex structures do. This variability
amongst the members of the decamer further support the hypothesis that L2 is flexible and it can either
stay close to or move away from SAM/SAH site.

FIG. 3. (a) The residues involved in SAH and glutamate binding (substrates in yellow). The apo CalS11 structure is colored
red (PDB 4PWR), complex structure is colored blue (PDB 3TOS).
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TABLE II. Statistics of ensemble refinement.
phenix.refine

ensemble.refinement (ER)

ER—phenix.refine

PDB ID

Resolution (Å)

Number of models

Rcryst

Rfree

Rcryst

Rfree

DRcryst

DRfree

4PWR

1.80

25

0.146

0.179

0.137

0.171

0.009

0.008

3TOS

1.55

20

0.166

0.195

0.138

0.172

0.028

0.023

4GF5

2.20

20

0.220

0.219

0.143

0.199

0.077

0.020

In the CalS11 structurally related protein, NovP, the substructure corresponding to L2 is a
half helix-half loop structure. It is also proposed to be flexible, forming a lid over the
co-substrate SAM serving as a gate (Figures 2(c) and 2(d)).39 This suggests that L2 probably
serves a similar function in both NovP and CalS11. In the complex structure, L2 forms a hydrophobic lid near the ribose and adenine ring of SAH and stabilizes SAH by van der Waals forces
and sterically hinders the release of SAH. Thus, the dynamics of the loop as observed here may
promote SAH release to complete the catalytic cycle.
C. Ensemble refinements

The ensemble refinement as applied here was performed using an X-ray data-restrained timeaveraged molecular dynamics simulation to generate an ensemble of models to represent the special
distribution and implies motion within protein molecules. It is an excellent tool to study structural dynamics. Application of ensemble refinement method to all three CalS11 structures improves the agreement between model and x-ray diffraction data, represented by decreases in Rfree compared to regular
refinement (Table II). Application of the ensemble refinement to apo CalS11 structure does reduce the
r.m.s.d. of the mFo-DFm difference map by 10%, although the ways the absolute scale is calculated
are slightly different in the two methods and may or may not account for this difference. Taken together, these results provide some evidence that the ensemble refinement improves model quality and
supports the idea that an ensemble of models somewhat better represents the structural dynamics of
CalS11 than a single static model. It certainly conveys a better visual description of the conformational variability than does simply removing parts of the model.
The ensemble refinement results for product bound structures are consistent with the standard structure determinations, with L2 staying in the closed state (Figures 4(b) and 4(c)).
However, in the ensemble refinement results for the apo structure, L2 is spatially distributed

FIG. 4. Comparison of ensemble models of apo CalS11 (PDBID 4PWR) and tertiary complexes CalS11 (PDBID 3TOS and
PDBID 4GF5). Protein regions with stable conformations show small displacements in these ensemble models, while disordered regions show large displacements. (a) The L2 region of apo CalS11 shows large displacements, while the most of the
structure shows small displacements. (b) and (c) Ensemble models of complexed CalS11 (PDBID 3TOS) and CalS11 (PDBID
4GF5) show small displacements, including the L2 region. These results show that the substrate binding site is more solvent accessible when no substrate is bound. All structures are shown in ribbon form, with substrates shown in lines using PYMOL.41
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FIG. 5. Active site accessibility comparison of three structures of CalS11: 4PWR (a), 3TOS (b), and 4GF5 (c). In all three
panels, two subunits were coloured pink and cyan, separately. L2 of the pink subunit is highlighted in hot pink. When substrate is bound (PDBID 3TOS, 4GF5), L2 covers the majority of the active site leaving little opening. When substrate is not
bound (a), the cavity can be completely exposed to solvent in many conformations.

between closed and open conformations (Figure 4(a)). The ensemble of L2 conformations did
not form a contact with neighboring unit cell. This indicates that the space displacement range
of L2 is not an artifact due to crystal packing. The active site is more exposed to solvent than
in the SAH bound structure as a result of L2 movement (Figure 5). Residues involving hydrophobic interactions with SAH (residues 111–113 and residues 128–133) show both main chain
and side chain conformation changes.
This mobility of L2 that we see in CalS11 appears to minimize the activation energy for
substrate binding, as the loop rearrangements open the conformation for substrate access. The
loops interactions with the substrate may also provide specificity for the substrate through
enthalpic interactions in intermediate states. If the energy landscape of a loop is very broad,
loop variability can also contribute an entropic component to the overall free energy of binding
that trades specificity or tightness of binding of products with conformational entropy. This
entropic component of the free energy is then recovered as the product leaves the active site.
IV. CONCLUSIONS

Dynamics of loops may confer advantages over highly fixed folded proteins in substrate
binding.40 The free energy flow can trade off attractive forces for the substrate bound form
with the entropy of a loop, allowing for specificity but retaining a reasonable equilibrium constant for product release. The diffusive motions of a loop in thermal equilibrium with the environment might also help “pull” off the substrate from its post-transition state like environment.
Many of these functionally important dynamics are retained in the crystalline forms of the protein as well. Their motions are just averaged by the nature of the analysis and are not well represented by a single model built based on standard practices. Compared to other methods of
characterizing the energy landscape of a large dynamic molecule, ensemble refinement is an
easier way of analyzing currently available structure data in protein databank and representing
protein dynamics in atomic detail with enhanced support from experimental data.
The general fold of CalS11 is stable in structures with or without SAH bound. Loop L2 of
CalS11 shows enhanced mobility in the absence of substrate. This mobility is visualized by ensemble refinement, which generated an ensemble of models by a restrained molecular dynamics
simulation that includes the X-ray diffraction data. Ensemble refinement results of three structures showed that L2 conformations are distributed between closed and open states. Ensemble
refinements provide us with a better representation of the mobile part of a protein structure,
both statistically and visually. It helps us identify the spatial distribution of L2 for CalS11,
presents a sampling of the conformational landscape, and provides evidence of dynamics of L2
supporting its function in promoting substrate binding and product release.
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